Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 2/20 | 0.42 |
| ▸ | LAP3 | P28838 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2851714 | 0.95 | SRC (0.54) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| SCHEMBL28015965 | 0.87 | SRC (0.47) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| SCHEMBL4018818 | 0.87 | SRC (0.47) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| SCHEMBL3888609 | 0.86 | SRC (0.45) | SRCL3MBTL1TDP1KDM4EMEN1 | |
| Triphenyl Phosphate SCHEMBL18116 | 0.85 | SRC (0.64) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| Triphenyl Phosphate SCHEMBL28557783 | 0.85 | SRC (0.64) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| Triphenyl Phosphate SCHEMBL483692 | 0.85 | SRC (0.64) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| Triphenyl Phosphate SCHEMBL28761613 | 0.85 | SRC (0.64) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| Triphenyl Phosphate SCHEMBL28200611 | 0.83 | SRC (0.56) | SRCL3MBTL1TDP1KDM4ECYP3A4 | |
| Triphenyl Phosphate SCHEMBL15815456 | 0.82 | SRC (0.61) | SRCL3MBTL1TDP1KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113620274-B | Method for preparing lignin-based carbon quantum dots with high quantum yield quickly, simply and conveniently | 广东工业大学 | 2023-03-24 | — | — | CN | claimed |
| CN-118702096-A | Method for recycling battery negative electrode graphite, regenerated graphite material prepared by method and application of regenerated graphite material | 广东邦普循环科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118541372-A | Bicyclic triazine derivatives for the treatment of cancer | 德国癌症研究中心 | 2024-08-23 | — | — | CN | disclosed |
| US-11963960-B2 | Compounds for treating or inhibiting recurrence of acute myeloid leukemia | FLASH THERAPEUTICS, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| CN-116507337-A | ATR inhibitors and uses thereof | 上海德琪医药科技有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-4121430-A1 | COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA | Flash Therapeuttics, LLC (US) | 2023-01-25 | — | — | EP | disclosed |
| US-11352329-B2 | HIV protease inhibitors | GILEAD SCIENCES, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| CN-113939300-A | STAT degradants and uses thereof | 凯麦拉医疗公司 | 2022-01-14 | — | — | CN | disclosed |
| US-20210299128-A1 | COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA | RIKEN (JP) | 2021-09-30 | — | — | US | disclosed |
| WO-2021188417-A1 | COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA | FLASH THERAPEUTICS, LLC (US) | 2021-09-23 | — | — | WO | disclosed |
| CN-1289745-C | Flameproof agent for polyester-based textile product and method of flameproof | DAIKYO CHEMICAL (JP) | 2006-12-13 | — | — | CN | disclosed |
| CN-1845907-A | Guanidine derivatives | ACTELION PHARMACEUTICALS LTD (CH) | 2006-10-11 | — | — | CN | disclosed |
| CN-1761673-A | guanidine derivatives and their use as neuropeptide FF receptor antagonists | ACTELION PHARMACEUTICALS LTD (CH) | 2006-04-19 | — | — | CN | disclosed |
| CN-1606646-A | Flameproof agent for polyester-based textile product and method of flameproof | DAIKYO CHEMICAL (JP) | 2005-04-13 | — | — | CN | disclosed |
| US-20040249029-A1 | Flameproofing agent for polyester-based textile product and method of flameproofing | DAIKYO CHEMICAL CO., LTD. (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1449955-A1 | FLAMEPROOFING AGENT FOR POLYESTER BASED TEXTILE PRODUCT AND METHOD OF FLAMEPROOFING | Daikyo Chemical Co., Ltd (JP) | 2004-08-25 | — | — | EP | disclosed |
| CN-1057085-C | Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives | BAYER AG (DE) | 2000-10-04 | — | — | CN | disclosed |
| CN-1108257-A | Heterocyclically substituted phenyl-cyclohexane-carboxylic acid derivatives | BAYER AG (DE) | 1995-09-13 | — | — | CN | disclosed |
| CN-1102645-A | Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives | BAYER AG (DE) | 1995-05-17 | — | — | CN | disclosed |
| CN-1082030-A | Propenoyl-imidazole derivatives | BAYER AG (DE) | 1994-02-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11963960-B2 | Compounds for treating or inhibiting recurrence of acute myeloid leukemia | MCL1, FLT3, ABL1 | SRC 95/4885L3MBTL1 299/4885TDP1 3548/4885 |
| US-11352329-B2 | HIV protease inhibitors | PRSS1, SERPINB1, FURIN | SRC 2825/4885L3MBTL1 2931/4885TDP1 1859/4885 |
| US-20210299128-A1 | COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA | MCL1, FLT3, ABL1 | SRC 95/4885L3MBTL1 299/4885TDP1 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.